364 filings
Page 10 of 19
UPLOAD
4piqxpn
30 Jul 12
Letter from SEC
12:00am
CORRESP
zs5let9pux q1e
27 Jul 12
Correspondence with SEC
12:00am
CORRESP
f6w44o
26 Jul 12
Correspondence with SEC
12:00am
F-1/A
wa21m
26 Jul 12
Registration statement (foreign) (amended)
12:00am
6-K
mi9skzn0p1dz07zbej9m
25 Jul 12
Rosetta Genomics and Precision Therapeutics Enter into Co-Marketing Agreement for miRview® mets2Assay
12:00am
UPLOAD
2yl0eslks39l25u7e
24 Jul 12
Letter from SEC
12:00am
6-K
zwgqg
24 Jul 12
Current report (foreign)
12:00am
6-K
712c38vs 5s
16 Jul 12
Current report (foreign)
12:00am
UPLOAD
7d62c9p4s ei
2 Jul 12
Letter from SEC
12:00am
6-K
qh4y5lgwivow
26 Jun 12
Rosetta Genomics Announces New York State Approval for miRview® lung
12:00am
F-1
nndhii
25 Jun 12
Registration statement (foreign)
12:00am
6-K
3ruw4oo0u
25 Jun 12
Current report (foreign)
12:00am
6-K
5ydffu1
22 Jun 12
Current report (foreign)
12:00am
6-K
0tt bu5vkvt84k
19 Jun 12
Rosetta Genomics Secures Medicare Reimbursement Pricing for miRview® mets2
12:00am
6-K
qsgiw
13 Jun 12
Current report (foreign)
12:00am
6-K
6m8su
6 Jun 12
Rosetta Genomics Appoints Roy N. Davis to Board of Directors
12:00am
6-K
ds697y0w gczaijupw
31 May 12
Current report (foreign)
12:00am
6-K
xu7kfqihtce3c8
25 May 12
Current report (foreign)
12:00am
6-K
gcywioyh
25 May 12
Current report (foreign)
12:00am
424B5
rb1ohgh287
25 May 12
Prospectus supplement for primary offering
12:00am